Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;45(8):3563-3571.
doi: 10.1007/s10072-024-07578-6. Epub 2024 May 9.

Multiple sclerosis and COVID-19: a northern China survey

Affiliations

Multiple sclerosis and COVID-19: a northern China survey

Qian Guo et al. Neurol Sci. 2024 Aug.

Abstract

Background: There is insufficient data on severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2) infection in Chinese patients with multiple sclerosis (pwMS). This study aims to explore the manifestation of pwMS during the Coronavirus disease 2019 (COVID-19) pandemic and the effect of SARS-CoV-2 infection on the prognosis of MS in northern China.

Methods: In this cross-sectional study, an online self-administered questionnaire and telephone interviews were conducted among pwMS of northern China. Clinical correlation of SARS-CoV-2 infection since the onset of the COVID-19 pandemic in northern China was analyzed.

Results: 164 patients with an average age of 38.9 ± 12.2 years were included, of which 57.3% had a disease course ≤ 5 years. 33.5% of the patients were COVID-19 vaccinated. 87.2% received disease-modifying therapy (DMT), and the average immunotherapy duration was 1.9 ± 1.6 years. 83.5% were SARS-CoV-2 infected, 14.6% reported worsening of their original condition after infection, and 5.1% had a relapse of MS. Shorter disease course was independently related to infection risk (P = 0.046), whereas increasing age was related to aggravated behavioral symptoms (P = 0.008). However, gender, vaccination, and DMT were not associated with susceptibility or poor prognosis.

Conclusion: A shorter disease course is independently associated with an increased risk of SARS-CoV-2 infection, and age is associated with worsening disability. It seems to be safe and necessary to use DMT during the pandemic, however, the use of B cell-depletion agents should be approached with caution.

Keywords: Coronavirus disease 2019; Disease course; Disease-modifying therapy; Multiple sclerosis; Severe acute respiratory syndrome coronavirus type-2.

PubMed Disclaimer

Conflict of interest statement

The author declares no competing interest.

References

    1. Sutradhar J, Sarkar BR. The effect on the immune system in the human body due to COVID-19: an insight on traditional to modern approach as a preventive measure. J Pharmacopuncture. 2021;24(4):165–172. doi: 10.3831/KPI.2021.24.4.165. - DOI - PMC - PubMed
    1. Sharma A, Ahmad Farouk I, Lal SK. COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention. Viruses. 2021;13(2):202. doi: 10.3390/v13020202. - DOI - PMC - PubMed
    1. Zhou X, Ye Q. Cellular immune response to COVID-19 and potential immune modulators. Front Immunol. 2021;30:12. doi: 10.3389/fimmu.2021.646333. - DOI - PMC - PubMed
    1. Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155–162. doi: 10.1097/BOR.0000000000000776. - DOI - PMC - PubMed
    1. Olek MJ (2021) Multiple sclerosis. Ann Intern Med 174(6):ITC81–96. 10.7326/AITC202106150 - PubMed

LinkOut - more resources